Euclidean Capital LLC holds a concentrated book of 11 reported positions worth $439.8M as of Q2 2026 (disclosed Aug 14, 2026, a ~45-day 13F lag). This quarter Teamshares Inc first appears in 13F filings, a listing rather than a purchase. Their largest long position is Vanguard Ftse All-World Ex-U at 62% of the reported non-option book.
Top-heavy: concentrated book
Excluding Vanguard Ftse All-World Ex-U (62% of the book), the rest is a concentrated book:
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
8% mapped to company sectors
+1 sector below the cut, under 0.5% together
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
No buys this quarter.
No trims or exits this quarter.
Other tracked managers holding the same core names as Euclidean Capital LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| CBIZ Investment Advisory Services, LLC | 2 / 11 | $932.0M |
| Threadgill Financial, LLC | 2 / 11 | $60.5M |
| Balentine LLC | 2 / 11 | $639.1M |
| 5th Street Advisors, LLC | 2 / 11 | $57.2M |
| Mill Creek Capital Advisors, LLC | 2 / 11 | $1.0B |
| Compass Planning Associates Inc | 2 / 11 | $38.5M |
| LPWM LLC | 2 / 11 | $68.8M |
| Lincoln National Corp | 2 / 11 | $595.4M |
Ranked by the share of each fund's own book sitting in the names it shares with Euclidean Capital LLC: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Vanguard Intl Equity Index F ALLWRLD EX US | $271.6M | 3.24M | 61.8% | —Held | |
| 2 | Vanguard Index FDS VALUE ETF | $113.3M | 520.0K | 25.8% | —Held | |
| 3 | Ishares TR MSCI INDIA ETF | $18.3M | 369.6K | 4.2% | —Held | |
| 4 | Oric Pharmaceuticals Inc COM | $10.7M | 989.4K | 2.4% | —Held | |
| 5 | Teamshares Inc COM | $9.0M | 1.10M | 2.1% | →Listed Newly reportable | |
| 6 | Foghorn Therapeutics Inc COM | $7.7M | 1.57M | 1.7% | —Held | |
| 7 | PMV Pharmaceuticals Inc COM | $3.5M | 2.63M | 0.8% | —Held | |
| 8 | Alector Inc COM | $2.6M | 1.31M | 0.6% | —Held | |
| 9 | Surrozen Inc COM NEW | $2.3M | 87.7K | 0.5% | —Held | |
| 10 | Tenaya Therapeutics Inc COM | $751K | 1.02M | 0.2% | —Held | |
| 11 | Surrozen Inc *W EXP 08/01/203 | $3K | 170.8K | <0.1% | —Held |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1825034/holdings"
Use Arkolith to show Euclidean Capital LLC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter. Raw filing totals can include option notional.
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.